NEW YORK (GenomeWeb) – Biocartis and Fast-track Diagnostics announced on Wednesday that they have formed a strategic collaboration to develop a range of multiplex tests for infectious diseases.

Under the arrangement, the companies will develop tests based on Fast-track's PCR-based infectious disease menu for use on Biocartis' Idylla automated molecular diagnostics platform. The first assay to be developed is expected to be a multiplex respiratory panel for the detection of viral and bacterial targets in upper respiratory tract infections.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.